Events, news, and information for the people who influence the business strategies of the life science industry.

REPORT - State of China Life Sciences: 2019

Share this article

With new investment records set across the board, it is the golden era of healthcare in China due to robust government support, sweeping regulatory changes, a strong talent base and more. Review the report compiled by ChinaBio® Group that uncovers the activity in 2018. Read the latest analysis of life science investment activity to get ahead for ChinaBio® Partnering Forum in Shanghai, May 8-9!

Topics Include:

  • VC Funds Raised
  • VC Investment
  • M&A Activity
  • IPOs
  • Partnering Activity

Download full report

Get a sneak peek at the 2018 investment activity in China from the report. New records were set across the board!

ChinaBioSource: ChinaBio® Consulting

 

Share this article

Upcoming event

BIO-Europe Spring

23 - 25 Mar 2020, Paris, France
Connect with the right partners at Europe’s largest springtime biotech partnering event
Go to site